|
|
Office Locations:
|
10 Laurel Ave Suite 130
Wellesley, MA 02481
Phone: 617-332-7227
Fax: 617-332-3113
| | |
|
|
|
|
|
Consumer Products & Services
Life Sciences & Healthcare
Medical Device
|
|
|
|
Launched in 1999, Sherbrooke Capital (SC) invests at the nexus of several industries: pharmaceuticals; food and beverages; and healthcare devices, products and services. Sherbrooke looks at opportunities in areas as diverse as: Functional foods and beverages, Nutritional ingredients businesses, Bioactives and therapeutic compounds, Prevention and self-care diagnostics and tools, Healthcare related consumer products and services, Minimally and non-invasive medical devices, and Medical informatics. Sherbrooke provides growth and expansion capital to companies which have already-developed products and services based upon proven science, with a proprietary position due to intellectual property or a strong brand franchise, and are seeking capital to initiate product roll-out or expand distribution and market presence. The firm is usually the first venture investor and part of a syndicate of venture investors. SC targets companies with generally $5 million - $25 million in revenues. SC will invest $1-4 million at a time, and potentially up to $10 million over several financing rounds. SC usually becomes a member of a company's board and will take a significant equity position.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
